Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

May 13, 2013
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business

May 8, 2013
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Investor FAQ

Where are your shares traded?

Bioniche shares trade on the Toronto Stock Exchange and on the Australian Securities Exchange, under the symbol "BNC".

When did Bioniche go public?

Bioniche Inc. became a public company on February 1, 1992. In July, 1999, Bioniche Inc. was amalgamated with Vetrepharm and Renaissance Life Sciences, a holding company, to form Bioniche Life Sciences Inc., operating both animal and human health businesses under one corporate umbrella.

When is the your fiscal year-end?

The Bioniche fiscal year ends June 30th.

Who are your auditors?

The company's auditors are Ernst & Young, LLP of Montréal, Québec.

Who is your legal counsel?

The company's legal counsel is Ogilvy Renault, Toronto, Ontario.

Who is your transfer agent?

CIBC Mellon Trust Company
c/o Canadian Stock Transfer Company Inc.
P.O. Box 700, Station B
Montreal, QC, H3B 3K3
Tel: 1 (800) 387-0825 / (416) 682-3860
Fax: 1 (888) 249-6189
E-mail: inquiries@canstockta.com
Website: www.canstockta.com

Link Market Services
Locked Bag A14
Sydney South NSW 1235
Tel.: 02 8280 7111
Fax: 02 9287 0303
E-mail: registrars@linkmarketservices.com.au

Who are the members of the Bioniche Board of Directors?

Biographies of the Bioniche senior management team and a listing of the company's Board members can be found here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy